All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10376805" target="_blank" >RIV/00216208:11110/18:10376805 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/18:43916903 RIV/00216208:11130/18:10376805 RIV/00064173:_____/18:N0000112 RIV/00064203:_____/18:10376805

  • Result on the web

    <a href="https://doi.org/10.3233/JAD-180039" target="_blank" >https://doi.org/10.3233/JAD-180039</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3233/JAD-180039" target="_blank" >10.3233/JAD-180039</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease

  • Original language description

    Background: Unlike antibodies against amyloid-beta, little is known about serum antibodies to neuron-specific cytoskeletal proteins in patients with Alzheimer&apos;s disease (AD). Objective: We aimed to study IgG autoantibodies against tau protein, light (NFL) and heavy subunits (NFH) of neurofilaments in serum of AD patients and elderly controls and to explore the evolution of antineurocytoskeletal antibody levels over time. Methods: Antibodies against three targets (tau, NFL, and NFH) were measured using ELISA in 100 serum samples from 51 cognitively normal elderly controls and 49 patients with AD. Our primary cross-sectional design was further extended to monitor fluctuations over 1-2 years in a subset of individuals. Results: The AD patients had lower levels of anti-tau antibodies (p = 0.03) and even lower anti-NFH antibodies (p = 0.005) than those in the control group at baseline. On the contrary, anti-NFL antibodies or total IgG concentrations in serum did not differ. All three antibodies remained stable in both groups except for a selective and significant anti-tau decline in AD patients (p = 0.03). Conclusions: The different responses to these antigens suggest some antibody selectivity in AD. The significant decline was observed for only serum anti-tau antibodies in AD patients over time and it corresponds to lower anti-tau levels in these patients. Our findings indicate a special feature of disease-relevant antigens and humoral autoimmunity in AD.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30103 - Neurosciences (including psychophysiology)

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Alzheimer&apos;s Disease

  • ISSN

    1387-2877

  • e-ISSN

  • Volume of the periodical

    64

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    10

  • Pages from-to

    751-760

  • UT code for WoS article

    000437257500006

  • EID of the result in the Scopus database

    2-s2.0-85049687560